02496.HK
Wuhan YZY Biopharma Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 3.80
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -11.81x
- Price / sales
- 7.39x
- Price / cash flow
- -15.67x
Enterprise value
- Enterprise value
- HKD 769.2M
- EV / sales
- 7.71x
- EV / EBITDA
- -7.33x
- EV / EBIT
- -6.60x
- Market cap
- HKD 736.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025